StocksB › BF.B

Brown-Forman Corporation (BF.B) — Earnings Call X-Ray

Our AI read all 38 of BF.B's earnings calls (2015–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q4 2025 · sign up to see
Previous Call Grade
D
Q3 2025
Expected Move
🔒
next 45 days · members
Calls Analyzed
38
2015–2025
Avg Candor
7.3/9
evasion 2.5/9
High CandorCritic AmmunitionEarly Product, Fast GrowthUnderused Fixed CostsPricing Under PressureMargins ContractingCutting HeadcountHidden Segment

Call-by-call analysis

🔒 Q4 2025 earnings call 2025-06-05 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q4 2025 call grade is ready
The full 37-point AI read of BF.B's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

D Q3 2025 earnings call 2025-03-05 move ±9%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: mixedMargins: contractingBacklog: stablePricing: under pressureHeadcount: cuttingCapex: flat 7 analysts · 12 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Early product, fast growthHidden segmentDirection beats results
Candor 7/9
Specificity 8/9
Evasion 4/9
Confidence 6/9
Uncertainty 6/9
Promotion 5/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q2 2025 earnings call 2024-12-05 move ±10.8%

Management held guidance steady against mixed demand signals and contracting margins. The delivery was unusually candid.

Guidance: maintainedDemand: mixedMargins: contractingPricing: raisingHeadcount: flatCapex: decreasing 9 analysts · 11 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubtsDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 6/9
Uncertainty 6/9
Promotion 4/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

F Q1 2025 earnings call 2024-08-29 move ±6.3%

Management held guidance steady against slowing demand and contracting margins. The delivery was rich in specifics.

Guidance: maintainedDemand: slowingMargins: contractingPricing: raisingCapex: flat 8 analysts · 15 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable⚑ Reads rehearsedHidden segmentDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q4 2024 earnings call 2024-06-05 move ±9.4%

Management held guidance steady against slowing demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: slowingMargins: expandingPricing: raisingCapex: flat 7 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedHidden segmentDirection beats results
Candor 6/9
Specificity 7/9
Evasion 4/9
Confidence 7/9
Uncertainty 5/9
Promotion 4/9
Stress 4/9
Complexity 7/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

F Q3 2024 earnings call 2024-03-06 move ±10.3%

Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid.

Guidance: loweredDemand: slowingMargins: expandingBacklog: shrinkingPricing: raisingCapex: decreasing 7 analysts · 9 questions
⚑ Critic ammunition⚑ Question left hanging✓ Early product, fast growth⚑ Reads rehearsedHidden segmentDirection beats results
Candor 7/9
Specificity 6/9
Evasion 3/9
Confidence 6/9
Uncertainty 5/9
Promotion 5/9
Stress 4/9
Complexity 5/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

C+ Q2 2024 earnings call 2023-12-06 move ±9.4%

Management lowered guidance against slowing demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: slowingMargins: expandingPricing: raisingCapex: flat 8 analysts · 17 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 8/9
Specificity 8/9
Evasion 2/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

C+ Q1 2024 earnings call 2023-08-30 move ±7.1%

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingPricing: raisingHeadcount: growingCapex: flat 7 analysts · 14 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
YES Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q4 2023 2023-06-07 B+ maintainedstablecontracting 7/9 2/9
Q3 2023 2023-03-08 C+ maintainedstablecontracting 7/9 3/9
Q2 2023 2022-12-07 B+ raisedstablecontracting 7/9 2/9
Q1 2023 2022-08-31 C+ maintainedstableexpanding 7/9 4/9
Q4 2022 2022-06-08 B+ maintainedstableexpanding 8/9 2/9
Q3 2022 2022-03-03 B+ raisedacceleratingcontracting 8/9 2/9
Q2 2022 2021-12-08 B+ raisedstablecontracting 8/9 2/9
Sep 2021 2021-09-01 C+ maintainedacceleratingcontracting 7/9 3/9
Q4 2021 2021-06-09 B maintainedacceleratingcontracting 8/9 2/9
Q2 2021 2020-12-08 C+ withdrawnmixedcontracting 7/9 3/9
Q1 2021 2020-09-02 D withdrawnmixedcontracting 7/9 4/9
Q4 2020 2020-06-09 D withdrawnmixedunclear 7/9 3/9
Q3 2020 2020-03-04 D loweredmixedcontracting 7/9 3/9
Q2 2020 2019-12-05 C+ maintainedstablecontracting 7/9 2/9
Q1 2020 2019-08-28 B maintainedstablecontracting 8/9 2/9
Q4 2019 2019-06-05 C+ maintainedmixedcontracting 7/9 3/9
Q3 2019 2019-03-06 C+ maintainedacceleratingcontracting 7/9 2/9
Q2 2019 2018-12-05 C+ maintainedstablecontracting 7/9 2/9
Q1 2019 2018-08-29 C+ loweredstablecontracting 8/9 2/9
Q4 2018 2018-06-06 B+ maintainedacceleratingcontracting 8/9 2/9
Q3 2018 2018-03-07 B maintainedacceleratingexpanding 7/9 2/9
Q2 2018 2017-12-06 B+ raisedacceleratingexpanding 7/9 2/9
Q1 2018 2017-08-30 A raisedacceleratingexpanding 7/9 1/9
Q4 2017 2017-06-07 B maintainedacceleratingexpanding 8/9 2/9
Q3 2017 2017-03-07 D loweredmixedcontracting 7/9 2/9
Q2 2017 2016-12-07 C loweredmixedcontracting 7/9 2/9
Q1 2017 2016-08-31 B maintainedmixedstable 8/9 2/9
Jun 2016 2016-06-08 B maintainedmixedstable 8/9 2/9
Q3 2016 2016-03-02 C+ loweredslowingexpanding 8/9 3/9
Q2 2016 2015-12-02 C+ maintainedstableexpanding 7/9 3/9

Research question bank — earlier calls

During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of BF.B's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.

B+ Q3 2022 earnings call 2022-03-03

1 more research questions answered NO

B Q1 2017 earnings call 2016-08-31

334 more research questions answered NO

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAC · AAC Holdings'AACAY · AAC Technologies HoldingAACG · ATA Creativity GlobalAADI · Aadi Bioscience, Inc.AALBF · Aalberts N.V.AAOI · Applied Optoelectronics,

BETR   All “B” companies    BFAGY

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.